For citations:
Gilyarevskiy SR, Shchedrina AY, Golshmid MV. Correction of certain pathophysiological components of the cardiovascular-renal metabolic syndrome (part two): The role of moxonidine. Meditsinskiy sovet = Medical Council. 2025;(16):19-27. (In Russ.) https://doi.org/10.21518/ms2025-444
JATS XML

































